Literature DB >> 30942880

Management Options for Gastric Variceal Hemorrhage.

Edward Wolfgang Lee1,2, Puja Shahrouki1, Lourdes Alanis1, Pengxu Ding1, Stephen T Kee1.   

Abstract

IMPORTANCE: Varices are one of the main clinical manifestations of cirrhosis and portal hypertension. Gastric varices are less common than esophageal varices but are often associated with poorer prognosis, mainly because of their higher propensity to bleed. OBSERVATIONS: Currently, treatments used to control and manage gastric variceal bleeding include β-blockers, endoscopic injection sclerotherapy, endoscopic variceal ligation, endoscopic variceal obturation, shunt surgery, transjugular intrahepatic portosystemic shunts, balloon-occluded retrograde transvenous obliteration (BRTO), and modified BRTO. In the past few decades, Western (United States and Europe) interventional radiologists have preferred transjugular intrahepatic portosystemic shunts that aim to decompress the liver and reduce portal pressure. Conversely, Eastern radiologists (Japan and South Korea) have preferred BRTO that directly targets the gastric varices. Over the past 20 years, BRTO has evolved and procedure-related risks have decreased. Owing to its safety and efficiency in treating gastric varices, BRTO is now starting to gain popularity among Western interventional radiologists. In this review, we present a comprehensive literature review of current and emerging management options, including BRTO and modified BRTO, for the treatment of gastric varices in the setting of cirrhosis and portal hypertension. CONCLUSIONS AND RELEVANCE: Balloon-occluded retrograde transvenous obliteration has emerged as a safe and effective alternative treatment option for gastric variceal hemorrhage. A proper training, evidence-based consensus and guideline, thorough preprocedural and postprocedural evaluation, and a multidisciplinary team approach with BRTO and modified BRTO are strongly recommended to ensure best patient care.

Entities:  

Mesh:

Year:  2019        PMID: 30942880     DOI: 10.1001/jamasurg.2019.0407

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  7 in total

1.  Transcatheter Embolization of Renal-Splenic Shunt to Treat Hematemesis.

Authors:  Neema Jamshidi; Stephen T Kee
Journal:  Cardiovasc Intervent Radiol       Date:  2020-07-24       Impact factor: 2.797

2.  Risk assessment of first upper gastrointestinal bleeding using computerized tomoscanning in esophageal varices patients with cirrhosis and portal hypertension.

Authors:  Wei Xie; Fa-Xiang Chen; Li-Yao Zhu; Cheng-Cai Wen; Xin Zhang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

Review 3.  Chinese guidelines on the management of liver cirrhosis (abbreviated version).

Authors:  Xiao-Yuan Xu; Hui-Guo Ding; Wen-Gang Li; Jing-Hang Xu; Ying Han; Ji-Dong Jia; Lai Wei; Zhong-Ping Duan; En-Qiang Ling-Hu; Hui Zhuang
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

4.  Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis.

Authors:  Han Ah Lee; Jungwon Kwak; Sung Bum Cho; Young-Sun Lee; Young Kul Jung; Ji Hoon Kim; Seung Up Kim; Hyonggin An; Hyung Joon Yim; Jong Eun Yeon; Yeon Seok Seo
Journal:  BMC Gastroenterol       Date:  2022-07-26       Impact factor: 2.847

5.  Interventional radiology followed by endoscopic drainage for pancreatic fluid collections associated with high bleeding risk: Two case reports.

Authors:  Ning Xu; Long-Song Li; Wen-Yi Yue; Dan-Qi Zhao; Jing-Yuan Xiang; Bo Zhang; Peng-Ju Wang; Ya-Xuan Cheng; En-Qiang Linghu; Ning-Li Chai
Journal:  World J Gastrointest Surg       Date:  2022-08-27

6.  The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage.

Authors:  Jiacheng Liu; Chongtu Yang; Songjiang Huang; Chen Zhou; Qin Shi; Kun Qian; Songlin Song; Bin Xiong
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-05       Impact factor: 2.586

7.  The clinical applicability of percutaneous splenic vein stent implantation for pancreatic portal hypertension.

Authors:  Jingjing Liu; Qingbing Wang; Xiaoyi Ding; Qin Liu; Wei Huang; Junwei Gu; Zhongmin Wang; Wei Wu; Zhiyuan Wu
Journal:  BMC Gastroenterol       Date:  2022-03-25       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.